The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary disease

Aim.The aim of the study is the analysis of risk factors, influencing on the progression of chronic obstructive pulmonary disease. Materials and methods. 259 patients with chronic obstructive pulmonary disease (COPD) I and III stages, mean age 54,3±11,7 and the duration of the disease 10,1±5,7. Pati...

Full description

Bibliographic Details
Main Authors: V A Nikitin, I A Starodubtseva, L V Vasilieva, A V Popov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2018-01-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/32696/pdf
_version_ 1818174557621583872
author V A Nikitin
I A Starodubtseva
L V Vasilieva
A V Popov
author_facet V A Nikitin
I A Starodubtseva
L V Vasilieva
A V Popov
author_sort V A Nikitin
collection DOAJ
description Aim.The aim of the study is the analysis of risk factors, influencing on the progression of chronic obstructive pulmonary disease. Materials and methods. 259 patients with chronic obstructive pulmonary disease (COPD) I and III stages, mean age 54,3±11,7 and the duration of the disease 10,1±5,7. Patients were divided into 2 groups: I group (n=119) - with III stage of disease, II group (n=140) - COPD with I stage. 30 healthy were involved in control group. The risk factors of progression of COPD were determined with the use of regressive and correlative analyses. Results. The level of markers of systemic inflammation in serum of patients with COPD: TNF-α (RR 3,25); IL-8 (RR 2,1); hs-CRP (RR 3,52) in combination with traditional risk factors (long course of the disease (RR 2,3), age (RR 1,65), smoking (RR 1,65), and also obesity (RR 2,45), early menopause (RR 3,52), hereditary respiratory predisposition (RR 3,05), and also coexisting cardiovascular pathology increase the risk of COPD progression several times. Conclusion. According to the results of this trial, unmodified risk factors such as hereditary predisposition, early menopause, long course of the diseases and coexisting cardiovascular pathology contribute significantly on progression of COPD. The relative risk increases with increasing of concentration of markers of systemic inflammation (TNF-α, IL-8 and hs-CRP),that correlate with clinical manifestations of COPD: cough, shortness of breath on VAS in mm.
first_indexed 2024-12-11T19:46:18Z
format Article
id doaj.art-86e980c8056e46a79fa5b5aeebcf13c9
institution Directory Open Access Journal
issn 0040-3660
2309-5342
language Russian
last_indexed 2024-12-11T19:46:18Z
publishDate 2018-01-01
publisher "Consilium Medicum" Publishing house
record_format Article
series Терапевтический архив
spelling doaj.art-86e980c8056e46a79fa5b5aeebcf13c92022-12-22T00:52:54Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422018-01-01901273010.17116/terarkh201890127-3029449The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary diseaseV A Nikitin0I A Starodubtseva1L V Vasilieva2A V Popov3N.N. Burdenko Voronezh State Medical UniversityN.N. Burdenko Voronezh State Medical UniversityN.N. Burdenko Voronezh State Medical UniversityN.N. Burdenko Voronezh State Medical UniversityAim.The aim of the study is the analysis of risk factors, influencing on the progression of chronic obstructive pulmonary disease. Materials and methods. 259 patients with chronic obstructive pulmonary disease (COPD) I and III stages, mean age 54,3±11,7 and the duration of the disease 10,1±5,7. Patients were divided into 2 groups: I group (n=119) - with III stage of disease, II group (n=140) - COPD with I stage. 30 healthy were involved in control group. The risk factors of progression of COPD were determined with the use of regressive and correlative analyses. Results. The level of markers of systemic inflammation in serum of patients with COPD: TNF-α (RR 3,25); IL-8 (RR 2,1); hs-CRP (RR 3,52) in combination with traditional risk factors (long course of the disease (RR 2,3), age (RR 1,65), smoking (RR 1,65), and also obesity (RR 2,45), early menopause (RR 3,52), hereditary respiratory predisposition (RR 3,05), and also coexisting cardiovascular pathology increase the risk of COPD progression several times. Conclusion. According to the results of this trial, unmodified risk factors such as hereditary predisposition, early menopause, long course of the diseases and coexisting cardiovascular pathology contribute significantly on progression of COPD. The relative risk increases with increasing of concentration of markers of systemic inflammation (TNF-α, IL-8 and hs-CRP),that correlate with clinical manifestations of COPD: cough, shortness of breath on VAS in mm.https://ter-arkhiv.ru/0040-3660/article/viewFile/32696/pdfchronic obstructive pulmonary diseaserisk factorsprogressionmarkers of systemic inflammation
spellingShingle V A Nikitin
I A Starodubtseva
L V Vasilieva
A V Popov
The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary disease
Терапевтический архив
chronic obstructive pulmonary disease
risk factors
progression
markers of systemic inflammation
title The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary disease
title_full The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary disease
title_fullStr The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary disease
title_full_unstemmed The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary disease
title_short The complex analysis of risk factors, influencing on the progression of chronic obstructive ulmonary disease
title_sort complex analysis of risk factors influencing on the progression of chronic obstructive ulmonary disease
topic chronic obstructive pulmonary disease
risk factors
progression
markers of systemic inflammation
url https://ter-arkhiv.ru/0040-3660/article/viewFile/32696/pdf
work_keys_str_mv AT vanikitin thecomplexanalysisofriskfactorsinfluencingontheprogressionofchronicobstructiveulmonarydisease
AT iastarodubtseva thecomplexanalysisofriskfactorsinfluencingontheprogressionofchronicobstructiveulmonarydisease
AT lvvasilieva thecomplexanalysisofriskfactorsinfluencingontheprogressionofchronicobstructiveulmonarydisease
AT avpopov thecomplexanalysisofriskfactorsinfluencingontheprogressionofchronicobstructiveulmonarydisease
AT vanikitin complexanalysisofriskfactorsinfluencingontheprogressionofchronicobstructiveulmonarydisease
AT iastarodubtseva complexanalysisofriskfactorsinfluencingontheprogressionofchronicobstructiveulmonarydisease
AT lvvasilieva complexanalysisofriskfactorsinfluencingontheprogressionofchronicobstructiveulmonarydisease
AT avpopov complexanalysisofriskfactorsinfluencingontheprogressionofchronicobstructiveulmonarydisease